Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Biochemistry|December 16, 1986
Purification and characterization of an enkephalin-degrading dipeptidyl-aminopeptidase from porcine brainP Chérot, M C Fournié-Zaluski, J Laval
European Journal of Pharmacology|January 12, 1993
Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in miceF Noble, M C Fournié-Zaluski, B P Roques
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1992
Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matterR Maldonado, M C Fournié-Zaluski, B P Roques
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitorH Chen, B P Roques, M C Fournié-Zaluski
Journal of Medicinal Chemistry|October 1, 1981
Evidence of the preferential involvement of mu receptors in analgesia using enkephalins highly selective for peripheral mu or delta receptorsG Gacel, M C Fournié-Zaluski, E Fellion, et al.
Journal of Medicinal Chemistry|October 5, 2001
Long lasting antinociceptive properties of enkephalin degrading enzyme (NEP and APN) inhibitor prodrugsH Chen, F Noble, B P Roques, et al.
European Journal of Pharmacology|September 19, 1996
Similar involvement of several brain areas in the antinociception of endogenous and exogenous opioidsO Valverde, M C Fournié-Zaluski, B P Roques, et al.
Pageof 11